Chantal T Harris

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Molecular Docking

Dendritic Cells

Clinical Practice

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Chantal T Harris, Sivan Cohen
Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (2) (2024)
Chantal T Harris, Sivan Cohen
Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (2) (2024)
Chantal T Harris, Sivan Cohen
Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (2) (2024)
Chantal T Harris, Sivan Cohen
Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2024)